MDC CONNECTS 2021 - Complex Medicines: Ready for the Clinic/Scaling up for Success
The medicines industry is in a period of change. While small molecule therapeutics still make up 90% of approved medicines, patient expectations are driving the industry towards targeted, precision treatments, which require a shift towards stratified, complex medicines with more challenging discovery and development needs.
And in this final session, a panel of experts will describe how to prepare for the clinic; to formulate, scale up and navigate the regulatory approval process.
- The advantages of good formulation — Claire Patterson (SEDA Pharmaceutical Development Services)
- Overcoming the challenges of scaling up a complex medicine — Graham Worrall and Emily Port (CPI)
- Everything you want to know about development, but were afraid to ask! — Alan Boyd (Boyds)